Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
August 18, 1999
Design and synthesis of diaminopyrrolidinone inhibitors of human osteoclast cathepsin K
K J Duffy, L H Ridgers, R L DesJarlais, et al.
Journal of Equine Veterinary Science
|
June 23, 2024
Metagenomic characterization of the equine endometrial microbiome during anestrus
B A Heil, M van Heule, S K Thompson, et al.
Journal of Medicinal Chemistry
|
September 16, 1994
Rational design, synthesis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1'--P2' amide bond isostere
S K Thompson, K H Murthy, B Zhao, et al.
The Journal of Biological Chemistry
|
May 24, 1996
Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification
M J Bossard, T A Tomaszek, S K Thompson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 28, 2015
Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study
J M Bowen, I White, L Smith, et al.
Journal of Medicinal Chemistry
|
November 7, 1998
Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites
J M LaLonde, B Zhao, W W Smith, et al.
Biochemistry
|
August 29, 2001
Steady-state kinetic characterization of substrates and metal-ion specificities of the full-length and N-terminally truncated recombinant human methionine aminopeptidases (type 2)
G Yang, R B Kirkpatrick, T Ho, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimetic
S K Thompson, W W Smith, B Zhao, et al.
Bioorganic & Medicinal Chemistry
|
June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K
R W Marquis, Y Ru, D S Yamashita, et al.
Seminars in Cancer Biology
|
April 14, 2015
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
W G Jiang, A J Sanders, M Katoh, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Bioorganic & Medicinal Chemistry Letters
|
August 18, 1999
Design and synthesis of diaminopyrrolidinone inhibitors of human osteoclast cathepsin K
K J Duffy, L H Ridgers, R L DesJarlais, et al.
Journal of Equine Veterinary Science
|
June 23, 2024
Metagenomic characterization of the equine endometrial microbiome during anestrus
B A Heil, M van Heule, S K Thompson, et al.
Journal of Medicinal Chemistry
|
September 16, 1994
Rational design, synthesis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1'--P2' amide bond isostere
S K Thompson, K H Murthy, B Zhao, et al.
The Journal of Biological Chemistry
|
May 24, 1996
Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification
M J Bossard, T A Tomaszek, S K Thompson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 28, 2015
Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study
J M Bowen, I White, L Smith, et al.
Journal of Medicinal Chemistry
|
November 7, 1998
Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites
J M LaLonde, B Zhao, W W Smith, et al.
Biochemistry
|
August 29, 2001
Steady-state kinetic characterization of substrates and metal-ion specificities of the full-length and N-terminally truncated recombinant human methionine aminopeptidases (type 2)
G Yang, R B Kirkpatrick, T Ho, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimetic
S K Thompson, W W Smith, B Zhao, et al.
Bioorganic & Medicinal Chemistry
|
June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K
R W Marquis, Y Ru, D S Yamashita, et al.
Seminars in Cancer Biology
|
April 14, 2015
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
W G Jiang, A J Sanders, M Katoh, et al.
Page
of 7